By NewsDesk  @infectiousdiseasenews Seqirus announced today that it has begun to ship its portfolio of innovative seasonal influenza vaccines across the U.S. in preparation for the 2021/22 influenza...

By NewsDesk  @infectiousdiseasenews Scientists from Robert Koch Institute report a significant decrease in case notifications for almost all notifiable diseases during the first months of COVID-19 pandemic...

Biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, Moderna, announced Wednesday  the first participants have been dosed in the Phase 1/2 study of mRNA-1010, the Company’s...

By NewsDesk  @infectiousdiseasenews The Centers for Disease Control and Prevention (CDC) reported in their latest FluView a human infection with an influenza A(H1N1) variant (A(H1N1)v) virus reported...

By NewsDesk  @infectiousdiseasenews A new study looking across a large body of research finds further evidence for the safety of vaccines that are Food and Drug Administration-approved and routinely...

By NewsDesk  @infectiousdiseasenews The Manitoba, Canada government reported two separate cases of variant influenza viruses in the province in April in two separate areas of southern Manitoba. They...

By NewsDesk  @bactiman63 The Centers for Disease Control and Prevention (CDC) reported a case of human infection with a novel influenza A virus, or “swine flu” in North Carolina, in their...

By NewsDesk  @bactiman63 Seqirus announced this week that the U.S. Food and Drug Administration (FDA) has approved FLUCELVAX® QUADRIVALENT (Influenza Vaccine), the company’s cell-based quadrivalent...

More U.S. adults reported receiving or planning to receive an influenza vaccination during the 2020-2021 flu season than ever before, according to findings from a national survey. The survey of 1,027...

A new study published in CMAJ (Canadian Medical Association Journal) found that the risk of death from COVID-19 was 3.5 times higher than from influenza. “We can now say definitively that COVID-19...